Serum protein signatures differentiating autoimmune pancreatitis versus pancreatic cancer

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Felix, Klaus ^a   Hauck, Oliver ^a   Fritz, Stefan ^a   Hinz, Ulf ^a   Schnölzer, Martina ^b   Kempf, Tore ^b   Warnken, Uwe ^b   Michel, Angelika ^b   Pawlita, Michael ^b   Werner, Jens ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN E; BACTERIAL PROTEIN; BIOLOGICAL MARKER; CA 19-9 ANTIGEN; CAGA PROTEIN; CASPASE ACTIVATED DEOXYRIBONUCLEASE; HAPTOGLOBIN; IMMUNOGLOBULIN G4; PREALBUMIN; TETRANECTIN; VACUOLATING TOXIN;

ADULT; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNE PANCREATITIS; CARCINOGENESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEROPREVALENCE; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; BIOMETRY; BLOOD PROTEINS; DIAGNOSIS, DIFFERENTIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; PROTEOMICS;

EID: 84891922909     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082755     Document Type: Article

References (44)

1. Zamboni G, Luttges J, Capelli P, Frulloni L, Cavallini G, et al. (2004) Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 445: 552-563. (Pubitemid 40104530)
2. Okazaki K, Chiba T (2002) Autoimmune related pancreatitis. Gut 51: 1-4. (Pubitemid 34717730)
3. Detlefsen S, Zamboni G, Frulloni L, Feyerabend B, Braun F, et al. (2012) Clinical features and relapse rates after surgery in type 1 autoimmune pancreatitis differ from type 2: A study of 114 surgically treated European patients. Pancreatology 12: 276-283.
4. Chari ST, Kloeppel G, Zhang L, Notohara K, Lerch MM, et al. (2010) Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas 39: 549-554.
5. Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, et al. (2006) Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 4: 1010-1016; quiz 1934. (Pubitemid 44118845)
6. Zen Y, Bogdanos DP, Kawa S (2011) Type 1 autoimmune pancreatitis. Orphanet J Rare Dis 6: 82.
7. Kloppel G, Sipos B, Zamboni G, Kojima M, Morohoshi T (2007) Autoimmune pancreatitis: histo- and immunopathological features. J Gastroenterol 42 Suppl 18: 28-31. (Pubitemid 46863934)
8. Finkelberg DL, Sahani D, Deshpande V, Brugge WR (2006) Autoimmune pancreatitis. N Engl J Med 355: 2670-2676. (Pubitemid 44969126)
9. Irie H, Honda H, Baba S, Kuroiwa T, Yoshimitsu K, et al. (1998) Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol 170: 1323-1327.
10. Procacci C, Carbognin G, Biasiutti C, Frulloni L, Bicego E, et al. (2001) Autoimmune pancreatitis: possibilities of CT characterization. Pancreatology 1: 246-253. (Pubitemid 33674929)
11. Horiuchi A, Kawa S, Hamano H, Hayama M, Ota H, et al. (2002) ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc 55: 494-499. (Pubitemid 41123499)
12. Nakazawa T, Ohara H, Sano H, Aoki S, Kobayashi S, et al. (2004) Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc 60: 937-944. (Pubitemid 39655468)
13. Nishino T, Oyama H, Hashimoto E, Toki F, Oi I, et al. (2007) Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol 42: 550-559. (Pubitemid 47190072)
14. Law R, Bronner M, Vogt D, Stevens T (2009) Autoimmune pancreatitis: a mimic of pancreatic cancer. Cleve Clin J Med 76: 607-615.
15. van Gulik TM, Reeders JW, Bosma A, Moojen TM, Smits NJ, et al. (1997) Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc 46: 417-423. (Pubitemid 27498388)
16. Kamisawa T, Imai M, Yui Chen P, Tu Y, Egawa N, et al. (2008) Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas 37: e62-67.
17. Ehmann M, Felix K, Hartmann D, Schnolzer M, Nees M, et al. (2007) Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Pancreas 34: 205-214. (Pubitemid 46294796)
18. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, et al. (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344: 732-738. (Pubitemid 32204991)
19. Frulloni L, Lunardi C, Simone R, Dolcino M, Scattolini C, et al. (2009) Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 361: 2135-2142.
20. Michel A, Waterboer T, Kist M, Pawlita M (2009) Helicobacter pylori multiplex serology. Helicobacter 14: 525-535.
21. Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, et al. (2005) Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 51: 1845-1853. (Pubitemid 41368175)
22. Waterboer T, Sehr P, Pawlita M (2006) Suppression of non-specific binding in serological Luminex assays. J Immunol Methods 309: 200-204. (Pubitemid 43190816)
23. Wessel D, Flugge UI (1984) A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem 138: 141-143. (Pubitemid 14146660)
24. Yu KH, Rustgi AK, Blair IA (2005) Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. J Proteome Res 4: 1742-1751. (Pubitemid 41464802)
25. Gobom J, Schuerenberg M, Mueller M, Theiss D, Lehrach H, et al. (2001) Alpha-cyano-4-hydroxycinnamic acid affinity sample preparation. A protocol for MALDI-MS peptide analysis in proteomics. Anal Chem 73: 434-438.
26. Raina A, Krasinskas AM, Greer JB, Lamb J, Fink E, et al. (2008) Serum immunoglobulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis. Arch Pathol Lab Med 132: 48-53.
27. Ghazale A, Chari ST, Smyrk TC, Levy MJ, Topazian MD, et al. (2007) Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 102: 1646-1653. (Pubitemid 47206688)
28. Kamisawa T, Chari ST, Lerch MM, Kim MH, Gress TM, et al. (2013) Recent advances in autoimmune pancreatitis: type 1 and type 2. Gut 62: 1373-1380.
29. Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366: 539-551.
30. Uchida K, Okazaki K, Nishi T, Uose S, Nakase H, et al. (2002) Experimental immune-mediated pancreatitis in neonatally thymectomized mice immunized with carbonic anhydrase II and lactoferrin. Lab Invest 82: 411-424. (Pubitemid 34311114)
31. Wiley JW, Pietropaolo M (2009) Autoimmune pancreatitis: the emerging role of serologic biomarkers. Diabetes 58: 520-522.
32. Guarneri F, Guarneri C, Benvenga S (2005) Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? J Cell Mol Med 9: 741-744. (Pubitemid 44151961)
33. Kountouras J, Zavos C, Chatzopoulos D (2005) Autoimmune pancreatitis, Helicobacter pylori infection, and apoptosis: a proposed relationship. Pancreas 30: 192-193. (Pubitemid 40289461)
34. Kountouras J, Zavos C, Chatzopoulos D (2005) Less H. pylori not necessarily more GERD. Am J Gastroenterol 100: 249-250. (Pubitemid 41623296)
35. Kountouras J, Zavos C, Gavalas E, Tzilves D (2007) Challenge in the pathogenesis of autoimmune pancreatitis: potential role of helicobacter pylori infection via molecular mimicry. Gastroenterology 133: 368-369. (Pubitemid 47031162)
36. Rieder G, Karnholz A, Stoeckelhuber M, Merchant JL, Haas R (2007) H pylori infection causes chronic pancreatitis in Mongolian gerbils. World J Gastroenterol 13: 3939-3947. (Pubitemid 47272489)
37. Jesnowski R, Isaksson B, Mohrcke C, Bertsch C, Bulajic M, et al. (2010) Helicobacter pylori in autoimmune pancreatitis and pancreatic carcinoma. Pancreatology 10: 462-466.
38. Fakelman F, Felix K, Buchler MW, Werner J (2010) New pre-analytical approach for the deep proteome analysis of sera from pancreatitis and pancreas cancer patients. Arch Physiol Biochem 116: 208-217.
39. Hartmann D, Felix K, Ehmann M, Schnolzer M, Fiedler S, et al. (2007) Protein expression profiling reveals distinctive changes in serum proteins associated with chronic pancreatitis. Pancreas 35: 334-342. (Pubitemid 350307376)
40. Chen J, Chen LJ, Yang RB, Xia YL, Zhou HC, et al. (2013) Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma. Med Oncol 30: 583.
41. Fung ET, Yip TT, Lomas L, Wang Z, Yip C, et al. (2005) Classification of cancer types by measuring variants of host response proteins using SELDI serum assays. Int J Cancer 115: 783-789. (Pubitemid 40776702)
42. Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, et al. (2006) Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 116: 271-284. (Pubitemid 43121812)
43. Honda K, Okusaka T, Felix K, Nakamori S, Sata N, et al. (2012) Altered plasma apolipoprotein modifications in patients with pancreatic cancer: protein characterization and multi-institutional validation. PLoS One 7: e46908.
44. Qian WJ, Jacobs JM, Camp DG, 2nd, Monroe ME, Moore RJ, et al. (2005) Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry. Proteomics 5: 572-584. (Pubitemid 40262074)